Cite
HARVARD Citation
Kruis, W. et al. (2001). Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses. Gut. 49 (6), pp. 783-789. [Online].